Shree Ganesh Bio-Tech (India) Share Price

  • 1.15-0.01 (-0.86%)
  • Volume: 22,25,643
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:55 PM IST
Loading...

Shree Ganesh Bio-Tech (...

  • 1.15-0.01 (-0.86%)
  • Volume: 22,25,643
Advertisment

Shree Ganesh Bio-Tec share price insights

  • Company has spent less than 1% of its operating revenues towards interest expenses and 0.91% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Stock gave a 3 year return of -83.01% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

  • Shree Ganesh Bio-Tech (India) Ltd. share price moved down by -0.86% from its previous close of Rs 1.16. Shree Ganesh Bio-Tech (India) Ltd. stock last traded price is 1.15

    Share PriceValue
    Today/Current/Last-1.15
    Previous Day-1.16

InsightsShree Ganesh Bio-Tec

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    48.60
    EPS - TTM
    (₹)
    0.02
    MCap
    (₹ Cr.)
    45.84
    Sectoral MCap Rank
    21
    PB Ratio
    (x)
    0.73
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    1.00
    Beta

    Beta

    1 Month0.00
    3 Months0.00
    6 Months0.00
    1 Year0.02
    3 Years-

    0.00
    VWAP
    (₹)
    1.14
    52W H/L
    (₹)
    1.89 / 0.70

    Shree Ganesh Bio-Tec Share Price Returns

    1 Day-0.86%
    1 Week-0.86%
    1 Month-7.26%
    3 Months-1.71%
    1 Year9.52%
    3 Years-83.01%
    5 Years-79.82%

    ET Stock ScreenersTop Score Companies

    Check whether Shree Ganesh Bio-Tec belongs to analysts' top-rated companies list?

    View Stock Screeners

    Shree Ganesh Bio-Tec Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Shree Ganesh Bio-Tec Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Shree Ganesh Bio-Tec Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 0.91% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income3.924.844.124.128.25
      Total Income Growth (%)-18.9017.390.11-50.11-3.60
      Total Expenses3.694.304.044.048.10
      Total Expenses Growth (%)-14.186.45-0.18-50.11-4.26
      EBIT0.240.540.090.080.15
      EBIT Growth (%)-56.25526.1515.43-49.6754.98
      Profit after Tax (PAT)0.240.540.090.080.15
      PAT Growth (%)-56.25526.1515.43-49.6754.98
      EBIT Margin (%)6.0611.232.111.831.81
      Net Profit Margin (%)6.0611.232.111.831.81
      Basic EPS (₹)0.010.010.000.000.00
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue21.3363.0272.6917.212.47
      Total Revenue Growth (%)-66.15-13.31322.30596.07-57.86
      Total Expenses20.4860.3169.2016.512.24
      Total Expenses Growth (%)-66.04-12.85319.20637.85-45.15
      Profit after Tax (PAT)0.622.042.530.320.24
      PAT Growth (%)-69.55-19.29697.4034.31-86.82
      Operating Profit Margin (%)4.214.344.814.119.55
      Net Profit Margin (%)3.063.263.471.849.53
      Basic EPS (₹)0.020.050.130.160.12

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets73.6279.5293.5574.6364.72
      Total Assets Growth (%)-7.42-15.0025.3515.310.98
      Total Liabilities10.6417.1733.2416.847.24
      Total Liabilities Growth (%)-38.03-48.3597.39132.605.69
      Total Equity62.9862.3660.3257.7957.48
      Total Equity Growth (%)0.993.384.380.540.42
      Current Ratio (x)0.351.161.321.712.96
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 10.21 cr for investing activities which is an YoY increase of 1.14%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities10.1610.543.572.36-1.01
      Net Cash used in Investing Activities-10.21-10.09-3.37-2.360.99
      Net Cash flow from Financing Activities---0.19--
      Net Cash Flow-0.050.440.010.01-0.02
      Closing Cash & Cash Equivalent0.430.480.040.020.02
      Closing Cash & Cash Equivalent Growth (%)-10.851,262.6645.6835.44-54.96
      Total Debt/ CFO (x)0.000.000.000.08-0.19

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)0.983.264.180.540.41
      Return on Capital Employed (%)1.354.355.801.220.40
      Return on Assets (%)0.842.562.690.420.36
      Interest Coverage Ratio (x)0.000.000.001,770.57444.33
      Asset Turnover Ratio (x)0.260.720.8623.063.82
      Price to Earnings (x)68.0320.0073.53769.231,111.11
      Price to Book (x)0.660.653.074.094.52
      EV/EBITDA (x)48.4314.8052.95333.771,093.61
      EBITDA Margin (%)4.214.344.814.119.60

      No reported Financial Ratios are available.

    Financial InsightsShree Ganesh Bio-Tec

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 0.91% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 10.21 cr for investing activities which is an YoY increase of 1.14%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Shree Ganesh Bio-Tec Peer Comparison

    • Shree Ganesh Bio-Tec Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -83.01% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -83.01% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Shree Ganesh Bio-Tec48.600.730.981.350.847.344.213.060.020.350.000.00
      Kaveri Seed Co.17.184.3724.2324.9314.563.8027.9526.1154.581.980.000.00
      Adv Enzyme Tech35.653.6110.0614.408.688.8633.0021.9511.927.610.020.18
      Nath Bio-Genes 10.290.716.497.644.502.5014.1911.9119.522.180.181.48
      Mangalam Seeds20.073.9918.8920.589.7439.2916.9711.7312.011.660.82-84.37
      Add More
      Annual Ratios (%)

      Choose from Peers

      • JK Agri Gen
      • Agri-Tech (India)
      • Genesis IBRC India

      Choose from Stocks

      Peers InsightsShree Ganesh Bio-Tec

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -83.01% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Shree Ganesh Bio-Tec Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Shree Ganesh Bio-Tec Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters0.000.000.000.00
        Pledge0.000.000.000.00
        FII1.421.422.172.17
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others98.5898.5897.8397.83
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        FII56,64,9401.42 %0.00
        Others39,29,59,06098.58 %0.00

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Shree Ganesh Bio-Tec Board Meeting/AGM

      • Shree Ganesh Bio-Tec Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 13, 2024Jul 30, 2024Board MeetingQuarterly Results
        May 30, 2024May 22, 2024Board MeetingAudited Results
        Feb 13, 2024Jan 18, 2024Board MeetingQuarterly Results
        Nov 08, 2023Oct 26, 2023Board MeetingQuarterly Results
        Sep 28, 2023Sep 07, 2023AGMA.G.M.
      • Dividend announcements are not available.

      • All TypesEx-DateRecord DateAnnounced onDetails
        BonusApr 27, 2022Apr 28, 2022Mar 07, 2022Bonus Ratio: 1 share(s) for every 1 shares held
        SplitsFeb 10, 2022Feb 11, 2022Dec 20, 2021Split: Old FV10.0| New FV:1.0

      About Shree Ganesh Bio-Tec

      Shree Ganesh Bio-Tech (India) Ltd., incorporated in the year 1982, is a Small Cap company (having a market cap of Rs 45.84 Crore) operating in Agriculture/Horticulture/Livestock sector. Shree Ganesh Bio-Tech (India) Ltd. key Products/Revenue Segments include Tissue Cultured Plants for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • AP

        Aman Patel

        Whole Time Director
        AP

        Aman Patel

        Whole Time Director
        AP

        Aman Patel

        Whole Time Director
        KN

        Kishan Nityanand Naidu

        Executive Director
        Show More
      • Bipin & Co.

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times